Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2021.1872344 http://scihub22266oqcxt.onion/10.1080/21645515.2021.1872344 33544024!8475553!33544024     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2021 ; 17 (8): 2451-2453 Nephropedia Template TP {{tp|p=33544024|t=2021. Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany |pdf=|usr=}}{{33544024}} gab.com Text Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33544024 #FOAvip Bacillus Calmette-Guerin (BCG) vaccine is known to have "bystander benefits" in protecting against heterologous infections; interim analysis of the "ACTIVATE" trial shows protection against respiratory infections in the elderly population. Epidemiologic studies suggest a potential benefit of BCG vaccination on COVID-19 outcomes. Differential past BCG vaccination policies between the former East and West German states provides a unique natural experiment to assess the potential effect of prior BCG vaccination on COVID-19. We estimated a 5% heterologous vaccine efficacy in the highly vaccinated former East Germany using the COVID-19 International Modeling (CoMo) Consortium model. A comparable BCG vaccination campaign undertaken prior to the pandemic in former West Germany, instituted along with known country-wide transmission reduction measures, is associated with a 37% decrease in projected mortality by mid-summer, 2020. These findings support a combined heterologous vaccine and non-pharmaceutical interventions (HVI+NPI) approach to mitigate the SARS-CoV-2 pandemic until SARS-CoV-2 specific vaccines are widely distributed. Twit Text FOAVip Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33544024 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33544024 #FOAvip English Wikipedia <ref>{{Cite pmid|33544024}}</ref> Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany #MMPMID33544024 Marin-Hernandez D; Nixon DF; Hupert N Hum Vaccin Immunother 2021[Aug]; 17 (8): 2451-2453 PMID33544024show ga Bacillus Calmette-Guerin (BCG) vaccine is known to have "bystander benefits" in protecting against heterologous infections; interim analysis of the "ACTIVATE" trial shows protection against respiratory infections in the elderly population. Epidemiologic studies suggest a potential benefit of BCG vaccination on COVID-19 outcomes. Differential past BCG vaccination policies between the former East and West German states provides a unique natural experiment to assess the potential effect of prior BCG vaccination on COVID-19. We estimated a 5% heterologous vaccine efficacy in the highly vaccinated former East Germany using the COVID-19 International Modeling (CoMo) Consortium model. A comparable BCG vaccination campaign undertaken prior to the pandemic in former West Germany, instituted along with known country-wide transmission reduction measures, is associated with a 37% decrease in projected mortality by mid-summer, 2020. These findings support a combined heterologous vaccine and non-pharmaceutical interventions (HVI+NPI) approach to mitigate the SARS-CoV-2 pandemic until SARS-CoV-2 specific vaccines are widely distributed. |*BCG Vaccine[MESH] |*COVID-19[MESH] |Aged[MESH] |Germany/epidemiology[MESH] |Humans[MESH] |SARS-CoV-2[MESH]Anticipated reduction in COVID-19 mortality due to population-wide BCG(epmc).pdf DeepDyve Pubget Overpricing